Medsyn Therapeutics

Bengaluru, India Founded: 1991 • Age: 35 yrs
Development of synthetic therapeutics in healthcare.

About Medsyn Therapeutics

Medsyn Therapeutics is a Healthcare company based in Bengaluru (India) founded in 1991. Development of synthetic therapeutics in healthcare. Its Indian entity Medsyn Therapeutics Private Limited reported revenue of β‚Ή9 Lakh. Medsyn Therapeutics offers products and services including Synthetic Drugs and Biotechnology Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Research and Development and Biotechnology.

Company details

MedSyn Therapeutics is identified as an entity in the healthcare industry, specializing in synthetic therapeutics. It is involved in the research and development of biotechnological products for medical applications. Operations are conducted primarily in the B2B sector, with services including drug manufacturing and distribution. The company is based in Boston, USA, where efforts are focused on advancing pharmaceutical solutions. Synthetic drugs are produced to address various treatments, ensuring contributions to health innovations are made efficiently.

Key Metrics
  • Annual Revenue
    ₹9 Lakh

    FY 2025 · +29% YoY

  • Net Loss
    -₹14.4 Lakh

    FY 2025 · -160% margin

  • EBITDA
    -₹19.5 Lakh

    FY 2025 · -216% margin

Products & Services of Medsyn Therapeutics

Medsyn Therapeutics offers a comprehensive portfolio of products and services, including Synthetic Drugs and Biotechnology Services.

Synthetic Drugs
Healthcare Products

Synthetic drugs are developed for therapeutic uses in medical treatments

Biotechnology Services
Research Services

Biotechnology research services are provided for drug development and innovation

Board of directors of Medsyn Therapeutics Private Limited (Medsyn Therapeutics)

Medsyn Therapeutics Private Limited is the primary company behind Medsyn Therapeutics. The board of Medsyn Therapeutics Private Limited currently have 2 directors; the longest-serving is Gowri Shankar Sugantha, appointed in 2007. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Gowri Shankar Sugantha
DIN 00910703
Director29 Jun 200719 yrs 4 moMedsyn Therapeutics Private Limited
Pandeshwara Narasimhamurthy Sharada Ithal
DIN 08949355
Director05 Nov 20205 yrs 11 moMedsyn Therapeutics Private Limited

Financials of Medsyn Therapeutics

Figures of Medsyn Therapeutics Private Limited, the primary company behind Medsyn Therapeutics, for FY 2025. Revenue was ₹9 Lakh (+29% year on year). Net loss was -₹14.4 Lakh (-160% margin). EBITDA was -₹19.5 Lakh (-216% margin).

  • ₹9 LakhRevenue · FY 2025 · +29% YoY
  • -₹14.4 LakhNet loss · -160% margin
  • -₹19.5 LakhEBITDA · -216% margin
  • ₹1.1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Medsyn Therapeutics Private Limited are on its company page.

Premium access

Detailed financial statements for Medsyn Therapeutics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Medsyn Therapeutics

Medsyn Therapeutics was founded in 1991.

Medsyn Therapeutics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

The primary company behind Medsyn Therapeutics, Medsyn Therapeutics Private Limited, reported revenue of β‚Ή9 Lakh for FY 2025, up 29% year on year.

MedSyn Therapeutics is identified as an entity in the healthcare industry, specializing in synthetic therapeutics. It is involved in the research and development of biotechnological products for medical applications. Operations are conducted primarily in the B2B sector, with services including drug manufacturing and distribution. The company is based in Boston, USA, where efforts are focused on advancing pharmaceutical solutions. Synthetic drugs are produced to address various treatments, ensuring contributions to health innovations are made efficiently.

Medsyn Therapeutics offers Synthetic Drugs and Biotechnology Services.

Medsyn Therapeutics operates through Medsyn Therapeutics Private Limited.

The legal entities of Medsyn Therapeutics currently have 2 directors, including Pandeshwara Narasimhamurthy Sharada Ithal, Gowri Shankar Sugantha.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available